299 related articles for article (PubMed ID: 34178028)
1. Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.
Cai S; Hu X; Chen R; Zhang Y
Front Genet; 2021; 12():657051. PubMed ID: 34178028
[TBL] [Abstract][Full Text] [Related]
2. Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma.
Wu P; Shi J; Wang Z; Sun W; Zhang H
Cancer Cell Int; 2022 Oct; 22(1):307. PubMed ID: 36217201
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma.
Gan Y; Yang Y; Wu Y; Li T; Liu L; Liang F; Qi J; Liang P; Pan D
Front Surg; 2022; 9():917061. PubMed ID: 36338651
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
5. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma.
Gao C; Zhou G; Cheng M; Feng L; Cao P; Zhou G
Front Genet; 2022; 13():956094. PubMed ID: 36330438
[No Abstract] [Full Text] [Related]
6. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
Zhou P; Lu Y; Zhang Y; Wang L
Front Oncol; 2021; 11():661758. PubMed ID: 34277410
[TBL] [Abstract][Full Text] [Related]
7. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
[TBL] [Abstract][Full Text] [Related]
8. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
[TBL] [Abstract][Full Text] [Related]
9. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
Huang S; Zhang J; Lai X; Zhuang L; Wu J
Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
[No Abstract] [Full Text] [Related]
11. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
12. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
13. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
Front Genet; 2021; 12():779554. PubMed ID: 34880908
[No Abstract] [Full Text] [Related]
14. A Glycolysis-Related Gene Signature Correlates With the Characteristics of the Tumor Immune Microenvironment and Predicts Prognosis in Patients With Hepatocellular Carcinoma.
Yang J; Zhang Y; Duan J; Huang X; Yu H; Hu Z
Front Mol Biosci; 2022; 9():834976. PubMed ID: 35573744
[No Abstract] [Full Text] [Related]
15. High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis
Jin X; Zhang S; Wang N; Guan L; Shao C; Lin Y; Liu J; Li Y
Front Oncol; 2022; 12():861601. PubMed ID: 35547872
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
18. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Lin Z; Xu Q; Miao D; Yu F
Front Oncol; 2021; 11():644416. PubMed ID: 33828988
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
